| Tucker Henry Trefz, PA | |
|
191 Theater Road, Onalaska, WI 54650 | |
| (608) 392-5000 | |
| Not Available |
| Full Name | Tucker Henry Trefz |
|---|---|
| Gender | Male |
| Speciality | Physician Assistant |
| Location | 191 Theater Road, Onalaska, Wisconsin |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710616933 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 7625 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Tucker Henry Trefz, PA 200 1st St Sw, Rochester, MN 55905-0001 Ph: (507) 284-2511 | Tucker Henry Trefz, PA 191 Theater Road, Onalaska, WI 54650 Ph: (608) 392-5000 |
News Archive
The gentle touch of a lesion on the tongue or cheek with a brush can help detect oral cancer with success rates comparable to more invasive techniques, according to preliminary studies by researchers at Rice University, the University of Texas Health Science Centers at Houston and San Antonio and the University of Texas M.D. Anderson Cancer Center.
Epilepsy affects 50 million people worldwide, but in a third of these cases, medication cannot keep seizures from occurring. One solution is to shoot a short pulse of electricity to the brain to stamp out the seizure just as it begins to erupt. But brain implants designed to do this have run into a stubborn problem: too many false alarms, triggering unneeded treatment. To solve this, Johns Hopkins biomedical engineers have devised new seizure detection software that, in early testing, significantly cuts the number of unneeded pulses of current that an epilepsy patient would receive.
Meibomian gland dysfunction is the leading cause of dry eye disease, which affects tens of millions of Americans. However, there is no FDA-approved treatment for MGD. Researchers from the Schepens Eye Research Institute/Massachusetts Eye and Ear and Harvard Medical School have just identified a potential therapy.
CytoSorbents Corporation, a critical care immunotherapy company using blood purification to treat life-threatening conditions, announced the launch of its International CytoSorb Treatment Registry, established and managed by the Center of Clinical Trials at the University of Jena, Germany.
The U.S. Food and Drug Administration's controversial decision to approve aducanumab for the treatment of Alzheimer's disease raises at least three major ethical issues that need to be addressed, states a new article in the Hastings Center Report:
› Verified 8 days ago
Elizabeth Twite, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 2727 Midwest Dr, Onalaska, WI 54650 Phone: 608-782-2027 Fax: 608-782-6172 | |
Katie Lyn Beahm, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 191 Theater Rd, Onalaska, WI 54650 Phone: 608-785-0940 | |
Leo Matthew Pedretti, Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 3111 Gundersen Dr, Onalaska, WI 54650 Phone: 608-775-8100 | |
Ivy L Heims, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 191 Theater Rd, Onalaska, WI 54650 Phone: 608-785-0940 | |
Mary E. Duh, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 191 Theater Rd, Onalaska, WI 54650 Phone: 608-392-5000 | |
James L Tomlin, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 3111 Gundersen Drive, Onalaska, WI 54650 Phone: 608-796-8630 | |
Anna M Carnahan, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 3111 Gundersen Dr, Onalaska, WI 54650 Phone: 608-775-8100 |